Donald R. O’Boyle

3.3k citations

37 papers · 2.4k indexed · 1 hit paper · h-index 25

Co-authors: Jin-Hua Sun Robert A. Fridell Chunfu Wang Julie A. Lemm Richard J. Colonno Peter T. Nower Nicholas A. Meanwell Lawrence B. Snyder
Topics: Hepatitis C virus research (21 papers)Herpesvirus Infections and Treatments (12 papers)Hepatitis B Virus Studies (12 papers)
Cited by: Hepatology Virology Epidemiology
Journals: Nature Journal of Biological Chemistry Hepatology
Partner nations: United States Germany Russia

In The Last Decade

Donald R. O’Boyle

37 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

2010 689 citations Min Gao, Richard E. Nettles et al. Nature profile →

Peers

Countries citing papers authored by Donald R. O’Boyle

Since Specialization

Citations

This map shows the geographic impact of Donald R. O’Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. O’Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. O’Boyle more than expected).

Fields of papers citing papers by Donald R. O’Boyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. O’Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. O’Boyle. The network helps show where Donald R. O’Boyle may publish in the future.

Co-authorship network of co-authors of Donald R. O’Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. O’Boyle. A scholar is included among the top collaborators of Donald R. O’Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. O’Boyle. Donald R. O’Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499 2025 ·Antimicrobial Agents and Chemotherapy ·(unknown),(unknown),(unknown),(unknown),(unknown),Brian McAuliffe,Paul Falk,Donald R. O’Boyle,Ronald E. Rose,(unknown),Chunxiang Wu,Yong Xiong,John F. Kadow,Umesh Hanumegowda,Luca Sardo,Eric P. Gillis,Mark Krystal,Robert A. Fridell	1
2	HCV NS5A replication complex inhibitors 2016 ·Current Opinion in Pharmacology ·Min Gao,Donald R. O’Boyle,Susan B. Roberts	15
3	Characterizations of HCV NS5A replication complex inhibitors 2013 ·Virology ·Donald R. O’Boyle,Jin-Hua Sun,Peter T. Nower,Julie A. Lemm,Robert A. Fridell,Chunfu Wang,J. Romine,Makonen Belema,Van N. Nguyen,Denis R. St. Laurent,Michael H. Serrano‐Wu,Lawrence B. Snyder,Nicholas A. Meanwell,David R. Langley,Min Gao	35
4	Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir 2013 ·Antimicrobial Agents and Chemotherapy ·Chunfu Wang,Jin-Hua Sun,Donald R. O’Boyle,Peter T. Nower,Lourdes Valera,Susan B. Roberts,Robert A. Fridell,Min Gao	80
5	1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO 2013 ·Journal of Hepatology ·Min Gao,Donald R. O’Boyle,Julie A. Lemm,Robert A. Fridell,(unknown),Stephen M. Roberts,(unknown),Peter T. Nower,(unknown),Benjamin M. Johnson,(unknown),Frederic Moulin,(unknown),Piyasena Hewawasam,John F. Kadow,Mark I. Cockett,Nicholas A. Meanwell,Makonen Belema,Jin-Hua Sun	3
6	Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052 2012 ·Hepatology ·Jin-Hua Sun,Donald R. O’Boyle,Yan Zhang,Chunfu Wang,Peter T. Nower,Lourdes Valera,Susan B. Roberts,Richard E. Nettles,Robert A. Fridell,Min Gao	41
7	HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies 2012 ·Bioorganic & Medicinal Chemistry Letters ·Omar D. Lopez,Van N. Nguyen,Denis R. St. Laurent,Makonen Belema,Michael H. Serrano‐Wu,(unknown),Fukang Yang,Yuping Qiu,Amy S. Ripka,Peter T. Nower,Lourdes Valera,Mengping Liu,Donald R. O’Boyle,Jin-Hua Sun,Robert A. Fridell,Julie A. Lemm,Min Gao,Andrew C. Good,Nicholas A. Meanwell,Lawrence B. Snyder	23
8	Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures 2011 ·Antimicrobial Agents and Chemotherapy ·Julie A. Lemm,John E. Leet,Donald R. O’Boyle,J. Romine,Xiaohua Huang,Daniel R. Schroeder,Jeffrey R. Alberts,Joseph L. Cantone,Jin-Hua Sun,Peter T. Nower,Scott Martin,Michael H. Serrano‐Wu,Nicholas A. Meanwell,Lawrence B. Snyder,Min Gao	38
9	The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization 2011 ·Journal of General Virology ·Dike Qiu,Julie A. Lemm,Donald R. O’Boyle,Jin-Hua Sun,Peter T. Nower,(unknown),Lawrence G. Hamann,Lawrence B. Snyder,(unknown),Edward H. Ruediger,Nicholas A. Meanwell,Makonen Belema,Min Gao,Robert A. Fridell	44
10	Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations 2010 ·Hepatology ·Robert A. Fridell,Chunfu Wang,Jin-Hua Sun,Donald R. O’Boyle,Peter T. Nower,Lourdes Valera,Dike Qiu,Susan B. Roberts,Xin Huang,Bernadette Kienzle,Marc Bifano,Richard E. Nettles,Min Gao	186
11	Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectbreakdown → 2010 ·Nature ·Min Gao,Richard E. Nettles,Makonen Belema,Lawrence B. Snyder,Van N. Nguyen,Robert A. Fridell,Michael H. Serrano‐Wu,David R. Langley,Jin-Hua Sun,Donald R. O’Boyle,Julie A. Lemm,Chunfu Wang,Jay O. Knipe,Caly Chien,Richard J. Colonno,Dennis M. Grasela,Nicholas A. Meanwell,Lawrence G. Hamann	689
12	Identification of Hepatitis C Virus NS5A Inhibitors 2009 ·Journal of Virology ·Julie A. Lemm,Donald R. O’Boyle,Mengping Liu,Peter T. Nower,Richard J. Colonno,Milind Deshpande,Lawrence B. Snyder,Scott Martin,Denis R. St. Laurent,Michael H. Serrano‐Wu,J. Romine,Nicholas A. Meanwell,Min Gao	149
13	Replication-Competent Chimeric Hepatitis C Virus Subgenomic Replicons 2005 ·Intervirology ·Julie A. Lemm,Mengping Liu,Ronald E. Rose,Robert A. Fridell,Donald R. O’Boyle,Richard J. Colonno,Min Gao	16
14	Functional Conservations of the Alkaline Nuclease of Herpes Simplex Type 1 and Human Cytomegalovirus 1998 ·Virology ·Min Gao,Barbara Robertson,P.J. McCann,Donald R. O’Boyle,Sandra K. Weller,William W. Newcomb,Jay C. Brown,Steven P. Weinheimer	17
15	Identification of a Novel Peptide Substrate of HSV-1 Protease Using Substrate Phage Display 1997 ·Virology ·Donald R. O’Boyle,Kevin A. Pokornowski,P.J. McCann,Steven P. Weinheimer	16
16	The Effect of Internal Autocleavage on Kinetic Properties of the Human Cytomegalovirus Protease Catalytic Domain 1995 ·Journal of Biological Chemistry ·Donald R. O’Boyle,Karen Wager‐Smith,John T. Stevens,Steven P. Weinheimer	31
17	Stimulation of the Herpes Simplex Virus Type I Protease by Antichaeotrophic Salts 1995 ·Journal of Biological Chemistry ·Gregory Yamanaka,Carolyn L. DiIanni,Donald R. O’Boyle,John T. Stevens,Steven P. Weinheimer,Ingrid C. Deckman,(unknown),Richard J. Colonno	29
18	In vitro Proteolytic Activity and Active‐Site Identification of the Human Cytomegalovirus Protease 1994 ·European Journal of Biochemistry ·John T. Stevens,Claudio Mapelli,(unknown),Mark E. Hail,Donald R. O’Boyle,Steven P. Weinheimer,Carolyn L. DiIanni	36
19	Identification of the serine residue at the active site of the herpes simplex virus type 1 protease. 1994 ·Journal of Biological Chemistry ·Carolyn L. DiIanni,John T. Stevens,Mark S. Bolgar,Donald R. O’Boyle,Steven P. Weinheimer,Richard J. Colonno	53
20	The sensitivity and specificity of various tuberculin tests using bovine PPD and other tuberculins 1978 ·Veterinary Record ·John Francis,Roger Seiler,(unknown),Donald R. O’Boyle,MA Lumsden,A. J. Frost	98

About Donald R. O’Boyle

Donald R. O’Boyle is a scholar working on Hepatology, Virology and Epidemiology, having authored 37 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), Herpesvirus Infections and Treatments (12 papers) and Hepatitis B Virus Studies (12 papers). The work is most often cited by research in Hepatology (1.4k citations), Virology (259 citations) and Epidemiology (1.8k citations). Donald R. O’Boyle has collaborated with scholars based in United States, Germany and Russia. Frequent co-authors include Jin-Hua Sun, Robert A. Fridell, Chunfu Wang, Julie A. Lemm, Richard J. Colonno, Peter T. Nower, Nicholas A. Meanwell, Lawrence B. Snyder, Min Gao and Steven P. Weinheimer. Their work appears in journals such as Nature, Journal of Biological Chemistry and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact